E-LIB Suche - Ergebnisse für: Fathi, Joelle T.

1

Tobacco Prevalence and Treatment:

, In: Respiratory Medicine; Lung Cancer,

Fathi, Joelle T. ; Kathuria, Hasmeena - p. 49-69 , 2023

Link: https://doi.org/10.1007/..

2

Integration of Tobacco Dependence Treatment in Lung Cancer ..:

, In: Respiratory Medicine; Tobacco Dependence,

Fathi, Joelle T. - p. 163-185 , 2023

Link: https://doi.org/10.1007/..

3

Getting ready for prime time: Recommended adaptations of an..:

Banerjee, Smita C ; Malling, Charlotte D ; Shen, Megan J...
Translational Behavioral Medicine. 13 (2023) 10 - p. 804-808 , 2023

Link: https://doi.org/10.1093/..

4

ASCT2-Targeting Antibody-Drug Conjugate MEDI7247 in Adult P..:

Maris, Michael ; Salles, Gilles ; Kim, Won Seog...
Targeted Oncology. 19 (2024) 3 - p. 321-332 , 2024

Link: https://doi.org/10.1007/..

5

Differentiation syndrome associated with treatment with IDH..:

Montesinos, Pau ; Fathi, Amir T. ; de Botton, Stéphane...
Blood Advances. 8 (2024) 10 - p. 2509-2519 , 2024

Link: https://doi.org/10.1182/..

6

Final phase 1 substudy results of ivosidenib for patients w..:

DiNardo, Courtney D. ; Roboz, Gail J. ; Watts, Justin M....
Blood Advances. 8 (2024) 15 - p. 4209-4220 , 2024

Link: https://doi.org/10.1182/..

7

Results from phase 1 of the MANIFEST clinical trial to eval..:

Stein, Eytan M. ; Fathi, Amir T. ; Harb, Wael A....
Leukemia & Lymphoma. 65 (2024) 4 - p. 503-510 , 2024

Link: https://doi.org/10.1080/..

8

Somatic gene mutation patterns and burden influence outcome..:

Risueño, Alberto ; See, Wendy L. ; Bluemmert, Iryna...
Leukemia Research. 140 (2024) - p. 107497 , 2024

Link: https://doi.org/10.1016/..

9

A phase 1 study of the irreversible FLT3 inhibitor FF-10101..:

Levis, Mark ; Perl, Alexander ; Schiller, Gary...
Blood Advances. 8 (2024) 10 - p. 2527-2535 , 2024

Link: https://doi.org/10.1182/..

10

Comparison of demographics, disease characteristics, and ou..:

Lesegretain, Arnaud ; Brunner, Andrew ; King, Andrew J....
Leukemia Research. 125 (2023) - p. 107006 , 2023

Link: https://doi.org/10.1016/..

11

POSTER: AML-446 Time to Resolution of Myelosuppression and ..:

Fathi, Amir T. ; Smith, B. Douglas ; Angiolillo, Anne...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S163 , 2023

Link: https://doi.org/10.1016/..

12

MDS-457 Ivosidenib in Mutant IDH1 Relapsed/Refractory Myelo..:

DiNardo, Courtney D. ; Roboz, Gail J. ; Watts, Justin M....
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S366-S367 , 2023

Link: https://doi.org/10.1016/..

13

AML-446 Time to Resolution of Myelosuppression and Associat..:

Fathi, Amir T. ; Smith, B. Douglas ; Angiolillo, Anne...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S302 , 2023

Link: https://doi.org/10.1016/..

14

AML-370 Phase IB OMNIVERSE Trial: Safety and Tolerability o..:

Fleming, Shaun ; Roboz, Gail J. ; Fathi, Amir T....
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S293 , 2023

Link: https://doi.org/10.1016/..

15

Targeting CD70 in acute myeloid leukaemia: an emerging ther..:

Fathi, Amir T
The Lancet Haematology. 10 (2023) 11 - p. e868-e870 , 2023

Link: https://doi.org/10.1016/..